Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07874334 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase 1a/b Study of GPRC5D CART Therapy in Relapsed/Refractory Multiple Myeloma and Light-chain Amyloidosis

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
A Phase 1a/b Open-Label Study to Evaluate Safety and Preliminary Efficacy of GPRC5D CART Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma and Light-chain Amyloidosis.
Trial Details
NCT Number NCT07874334
Lead Sponsor Hadassah Medical Organization
Conditions
(from sponsor)		 Relapsed/Refractory Multiple Myeloma (RRMM), Light-Chain Amyloidosis
Related terms Amyloidosis, Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov